Intrinsiqs

Is Arcturus Therapeutics Holdings Inc. overvalued?

Arcturus Therapeutics Holdings Inc. (ARCT) — key valuation metrics and fundamentals.

No verdict
Price
$8.23
Fair value
Current P/E
Normal P/E
Market cap
$233.9M
Dividend yield
9.0%
Return on equity
-46.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ARCT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.